SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, taking place July 23-26 in Hollywood, Florida. The company will display the system throughout the event, with demonstrations in multiple breakout sessions and a live broadcast of a remote partial nephrectomy. The surgery will be performed by Dr. Amitabh Singh from the company's headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform.
The full press release is available at https://ibn.fm/YYYKE. SS Innovations International develops surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, which support various procedures including cardiac surgery. The company plans to expand the global presence of its cost-effective surgical robotic solutions.
Forward-looking statements in this article involve risks and uncertainties as detailed in the company's filings with the SEC. For more information, see the terms of use and disclaimers at http://IBN.fm/Disclaimer.
